Glow LifeTech (TSE:GLOW) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Glow Lifetech Corp. plans to issue 10 million shares to finalize its acquisition of Swiss Pharma, strengthening their strategic partnership in the cannabis and natural health sectors. Additionally, Glow intends to settle $510,470.44 in outstanding debt by issuing over 8 million shares, aiming to preserve cash for working capital.
For further insights into TSE:GLOW stock, check out TipRanks’ Stock Analysis page.